Retatrutide, a new dual stimulator of the GLP-1 target and glucose-dependent insulinotropic polypeptide (GIP) receptor , is demonstrating promising data in preliminary human trials . Current research https://bookmarklogin.com/story21513630/retatrutide-emerging-research-and-potential-clinical-applications